Abbott: Colorectal Neoplasms trials

The registry lists 18 Colorectal Neoplasms studies with Abbott as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 2 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act NowCompletedNCT03728348Results posted
• Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerCompletedNCT01397747Results posted
• First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal CancerActive, not recruitingNCT06398743
• Informed Choice - CompassTerminatedNCT05246839
• CORRECT Study of Minimal Residual Disease Detection in Colorectal CancerActive, not recruitingNCT05210283
• Stool Collection Sub-Study of Exact Sciences Protocol 2018-01CompletedNCT04473625
• Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"CompletedNCT04144751
• Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"CompletedNCT04144738
• Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act BoldCompletedNCT03821948
• Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act FastCompletedNCT03789162
• Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)TerminatedNCT03705013
• Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)CompletedNCT02503696
• Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract CancersTerminatedNCT02503631
• A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test IntervalCompletedNCT02419716
• Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel DiseaseCompletedNCT01819766
• Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation TestingCompletedNCT01600209
• Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesCompletedNCT01260168
• A Study of ABT-751 in Patients With Colorectal CancerCompletedNCT00073138Phase 2